Details for New Drug Application (NDA): 202824
✉ Email this page to a colleague
The generic ingredient in DOXAZOSIN MESYLATE is doxazosin mesylate. There are fourteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.
Summary for 202824
Tradename: | DOXAZOSIN MESYLATE |
Applicant: | Accord Hlthcare |
Ingredient: | doxazosin mesylate |
Patents: | 0 |
Pharmacology for NDA: 202824
Mechanism of Action | Adrenergic alpha-Antagonists |
Medical Subject Heading (MeSH) Categories for 202824
Suppliers and Packaging for NDA: 202824
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DOXAZOSIN MESYLATE | doxazosin mesylate | TABLET;ORAL | 202824 | ANDA | Accord Healthcare Inc. | 16729-211 | 16729-211-01 | 100 TABLET in 1 BOTTLE (16729-211-01) |
DOXAZOSIN MESYLATE | doxazosin mesylate | TABLET;ORAL | 202824 | ANDA | Accord Healthcare Inc. | 16729-211 | 16729-211-17 | 1000 TABLET in 1 BOTTLE (16729-211-17) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
Approval Date: | Jun 11, 2014 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 2MG BASE | ||||
Approval Date: | Jun 11, 2014 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 4MG BASE | ||||
Approval Date: | Jun 11, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription